deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02431754

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

A Post-Marketing Clinical Study of LY450190 (Combined With Alpha1 Blocker Treatment)

Sponsor: Eli Lilly and Company

Conditions Benign Prostatic Hyperplasia
Interventions Alpha1 Blocker Placebo Tadalafil
Updated 10 times since 2017 Last updated: Jun 2, 2017 Started: Apr 30, 2015 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02431754, this PHASE4 trial focuses on Benign Prostatic Hyperplasia and remains completed. Sponsored by Eli Lilly and Company, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~May 2017 · 3 months · monthly snapshotCompleted~May 2017 – ~Feb 2018 · 9 months · monthly snapshotCompleted~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 5 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Feb 2018 — Jun 2018 [monthly]

    Completed PHASE4

  3. May 2017 — Feb 2018 [monthly]

    Completed PHASE4

  4. Feb 2017 — May 2017 [monthly]

    Completed PHASE4

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eli Lilly and Company
  • Nippon Shinyaku Co., Ltd.
Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations